drugset / Trial / NCT00793468

Relapse Prevention Study in Newly Abstinent Smokers

NCT00793468

Phase 2 Withdrawn GlaxoSmithKline
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the effect of GSK598809 as compared to placebo in preventing recently-quit smokers from going back to smoking.

Timeline

Start
2008-12
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK598809 Unknown
Background Nicotine Replacement Transdermal Patch Unknown 21 mg Other

Indications